Vulvar Paget disease: A national retrospective cohort study

J Am Acad Dermatol. 2019 Oct;81(4):956-962. doi: 10.1016/j.jaad.2018.11.016. Epub 2018 Nov 17.

Abstract

Background: Vulvar Paget disease (VPD) is a rare skin disorder that is considered premalignant.

Objective: To assess the clinical course, treatment schedules, and effect of invasion and treatment on recurrence and survival in patients with VPD.

Methods: Data on women with VPD were retrieved from the medical files and pathology reports in all Dutch tertiary university medical centers. Disease-free survival and 5-year disease-specific survival were estimated by using Kaplan-Meier curves.

Results: Data on 113 patients whose VPD was diagnosed between 1991 and 2016 were analyzed; 77% had noninvasive VPD. Most of the women (65%) underwent a surgical procedure. Recurrences were reported in 40%. Of the women with noninvasive VPD, 8% developed invasion. There were no disease-specific deaths reported in the women with noninvasive VPD. The 5-year disease-specific survival rate was greater than 98% in noninvasive and microinvasive VPD, but significantly worse in invasive VPD (50% [P < .0005]).

Limitations: The main limitations of this study are its retrospective character and the fact that original pathology samples were not available for reassessment.

Conclusions: VPD is extremely rare, and the recurrence rates are high. Most patients have noninvasive VPD, which does not affect survival and should be considered a chronic disorder with limited invasive potential. In cases of invasive disease, survival decreases significantly.

Keywords: Paget disease; extramammary; recurrence; survival; vulva; vulvar neoplasms.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use
  • Disease-Free Survival
  • Female
  • Humans
  • Imiquimod / therapeutic use
  • Kaplan-Meier Estimate
  • Lymphatic Metastasis
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Recurrence, Local / pathology*
  • Netherlands
  • Paget Disease, Extramammary / secondary*
  • Paget Disease, Extramammary / therapy*
  • Retrospective Studies
  • Survival Rate
  • Vulvar Neoplasms / pathology*
  • Vulvar Neoplasms / therapy*
  • Vulvectomy

Substances

  • Antineoplastic Agents
  • Imiquimod